Click on the arrow to listen to the podcast.
If you’ve been prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor, you might be worried about developing a urinary tract infection (UTI). Despite the fact that the prescription information for the medication indicates that patients might be at an increased risk for UTIs while taking it, there is little conclusive evidence to form a concrete link. In fact, a recent study published in the Canadian Medical Association Journal shows that UTI rates did not rise for most patients while taking SGLT2s. Article
If you would like to follow our weekly podcast, you can sign up to receive the Diabetes Health weekly newsletter or sign up with your iTunes, Google Play and Spotify account.
You can also follow us on Twitter, Facebook and Instagram.